Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Publication year range
1.
Hum Cell ; 36(4): 1389-1402, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37269415

ABSTRACT

Periodontitis is a chronic inflammatory disease that is the main cause of tooth loss in adults, and the key to periodontitis treatment is the repair and regenerate of periodontal bone tissue. Psoralen is the main component of the Psoralea corylifolia Linn, which shows antibacterial, anti-inflammatoryand osteogenic activities. It promotes the differentiation of periodontal ligament stem cells toward osteogenesis. Exosomes secreted by stem cells play important roles in information transmission during the osteogenic differentiation process. The aim of this paper was to investigate the role of psoralen in regulating osteogenic miRNA information in periodontal stem cells and in periodontal stem cells exosomes and the specific mechanism of its action. Experimental results show that exosomes of human periodontal ligament stem cell origin treated with psoralen (hPDLSCs + Pso-Exos) were not significantly different from untreated exosomes (hPDLSC-Exos) in terms of size and morphology. Thirty-five differentially expressed miRNAs were found to be upregulated and 58 differentially expressed miRNAs were found to be downregulated in the hPDLSCs + Pso-Exos compared to the hPDLSC-Exos (P < 0.05). hsa-miR-125b-5p was associated with osteogenic differentiation. Among them, hsa-miR-125b-5p was associated with osteogenic differentiation. After hsa-miR-125b-5p was inhibited, the osteogenesis level of hPDLSCs was enhanced. In summary, the osteogenic differentiation of hPDLSCs was promoted by psoralen through the downregulation of hsa-miR-125b-5p gene expression in hPDLSCs, and the expression of the hsa-miR-125b-5p gene was also downregulated in exosomes. This finding provides a new therapeutic idea for using psoralen to promote periodontal tissue regeneration.


Subject(s)
Exosomes , MicroRNAs , Adult , Humans , Osteogenesis/genetics , Exosomes/genetics , Ficusin/pharmacology , Ficusin/metabolism , Cells, Cultured , MicroRNAs/metabolism , Stem Cells/physiology , Cell Differentiation/genetics , Periodontal Ligament
2.
IET Nanobiotechnol ; 17(4): 376-386, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37191270

ABSTRACT

The treatment of periodontitis focuses on controlling the progression of inflammation, reducing plaque accumulation, and promoting bone tissue reconstruction. Among them, the reconstruction of irregular bone resorption caused by periodontitis is a long-standing challenge. At present, the local drug treatment of periodontitis is mainly anti-inflammatory and antibacterial drugs. In this study, psoralen (Pso), a Chinese herbal medicine with anti-inflammatory, antibacterial, and osteogenic effects, was selected for the local treatment of periodontitis. Meanwhile, an injectable methacrylate gelatin (GelMA) platform loading with Pso was constructed. Pso-GelMA had the properties of fluidity, light cohesion, self-healing, and slow release, which could be better used in the deep and narrow structure of the periodontal pocket, and greatly increased the effectiveness of local drug delivery. The pore size of Gelma hydrogel did not change after loading Pso by SEM. In vitro, Pso-GelMA effectively upregulated the expression of osteogenic genes and proteins, increased alkaline phosphatase activity, promoted the mineralisation of rat bone marrow mesenchymal stem cells (BMSCs) extracellular matrix, and had significant antibacterial effects on Staphylococcus aureus and Fusobacterium nucleatum. Therefore, Pso-GelMA has immense promise in the adjuvant treatment of periodontitis.


Subject(s)
Osteogenesis , Periodontitis , Rats , Animals , Ficusin/pharmacology , Gelatin/chemistry , Hydrogels/chemistry , Anti-Bacterial Agents/pharmacology , Anti-Inflammatory Agents/pharmacology
3.
Inflammation ; 44(5): 1843-1855, 2021 Oct.
Article in English | MEDLINE | ID: mdl-33839980

ABSTRACT

To study the effects of psoralen on the intestinal barrier and alveolar bone loss (ABL) in rats with chronic periodontitis. Fifty-two 8-week-old specific pathogen-free (SPF) male Sprague-Dawley (SD) rats were randomly divided into the following four groups: Control group (Control), psoralen group of healthy rats (Pso), periodontitis model group (Model), and psoralen group of periodontitis rats (Peri+Pso). The alveolar bone resorption of maxillary molars was observed via haematoxylin-eosin staining and micro-computed tomography. The expression level of receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin (OPG) in periodontal tissues was evaluated by immunofluorescence staining. The changes in serum tumour necrosis factor (TNF)-α, interleukin (IL)-10, IL-6, intestinal mucosal occludin, and claudin-5 were detected using enzyme-linked immunosorbent assay (ELISA). The level of intestinal mucosal NOD2 was detected using immunohistochemical methods. DNA was extracted from the intestinal contents and the 16s rRNA gene was sequenced using an Illumina MiSeq platform. The expression of NOD2 protein in the intestinal tract of periodontitis rats decreased after intragastric psoralen administration. Psoralen increased the intestinal microbiota diversity of rats. The level of serum pro-inflammatory factor TNF-α decreased and the level of anti-inflammatory factor IL-10 increased. ABL was observed to be significantly decreased in rats treated with psoralen. Psoralen decreased the RANKL/OPG ratio of periodontitis rats. Psoralen may affect the intestinal immune barrier and ecological barrier, mediate immune response, promote the secretion of anti-inflammatory factor IL-10, and reduce the secretion of the pro-inflammatory factor TNF-α, thus reducing ABL in experimental periodontitis in rats.


Subject(s)
Alveolar Bone Loss/drug therapy , Chronic Periodontitis/drug therapy , Ficusin/pharmacology , Ficusin/therapeutic use , Intestinal Mucosa/drug effects , Alveolar Bone Loss/metabolism , Alveolar Bone Loss/pathology , Animals , Chronic Periodontitis/metabolism , Chronic Periodontitis/pathology , Inflammation Mediators/antagonists & inhibitors , Inflammation Mediators/metabolism , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Male , Rats , Rats, Sprague-Dawley , Treatment Outcome , X-Ray Microtomography/methods
4.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-751037

ABSTRACT

Objective@#To explore the best indication for veneers and to improve the repair success rate by investigating the effects of different types of dentin exposure on the shear bond strength of cast porcelain veneers with two new veneer bonding systems.@*Methods@#Bonding interfaces with 0%, 25%, 50%, 75% and 100% dentin exposure were designed and fabricated. The bonding interfaces were divided into groups A, B, C, D and E. Sixty 4-mm x 4-mm x 2-mm (length x width x thickness) ceramic specimens were bonded by using two bonding systems, The VN-A, VN-B, VN-C, VN-D and VN-E groups were bonded with Variolink bonding system, and the PF-A, PF-B, PF-C, PF-D and PF-E were bonded with Panavia F bonding system (six specimens per group). The bonded specimens were stored in a distilled water bath at (37 + 1)℃ for 24 hours. The fracture load was tested by a universal testing machine, and the fracture type was observed by scanning electron microscopy.@*Results @#The VN-A (25.14 ± 3.40 MPa), VN-B (22.54 ± 4.48 MPa), VN-C (19.59 ± 2.21 MPa), PF-A (20.61 ± 2.42 MPa), PF-B (18.08 ± 4.11 MPa), PF-C (17.06 ± 2.29 MPa) groups’ shear bond strengths were above 17 MPa. The VN-A group had the highest shear bond strength value. There was no statistically significant difference in bond strength between the VN-A group and the VN-B and VN-C groups (P > 0.05) or the PF-A and PF-B groups (P > 0.05); however, the differences between VN-A and the VN-D and VN-E groups (P < 0.05) and between PF-A and the PF-C and PF-D and PF-E groups (P < 0.05) were statistically significant. The differences between the VN-A group and PF-A group (P < 0.05) were statistically significant. The fracture modes of the VN-A, PF-A, VN-B, PF-B, and VN-C groups mainly included resin cement cohesive failure and mixed failure; the VN-D, VN-E, PF-C, PF-D and PF-E groups were dominated by interface failure and mixed failure.@*Conclusion@#When the dentin exposure is greater than 50%, the shear bond strength value of the veneer was significantly affected. To obtain a better clinical effect, the dentin exposure rate should be less than 25%.

SELECTION OF CITATIONS
SEARCH DETAIL
...